§ Tim Loughton
To ask the Secretary of State for Health what representatives concerned with treatment of colorectal cancer sit on NICE appraisal panels assessing drugs used to treat colorectal cancer. 
§ Yvette Cooper
[holding answer 29 April 2002]: Membership of the National Institute of Clinical Excellence appraisal panels are decided by the Institute. However, I understand that organisations representing patients and professionals had the opportunity to submit evidence, to nominate experts and patients to speak directly to the appraisal committee, and to participate in consultation on the committee's provisional determination. I understand that nominees of the Royal College of Surgeons (a reader in medical oncology) and the Royal College of Nursing (a colorectal cancer nurse specialist) attended the first meeting of the appraisal committee.